These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1695222)
21. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea. Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286 [TBL] [Abstract][Full Text] [Related]
22. Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. Conley AJ; Kessler JA; Boots LJ; Tung JS; Arnold BA; Keller PM; Shaw AR; Emini EA Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3348-52. PubMed ID: 7512731 [TBL] [Abstract][Full Text] [Related]
23. Fine mapping of an immunodominant region of the transmembrane protein of the human immunodeficiency virus (HIV-1). Döpel SH; Porstmann T; Henklein P; von Baehr R J Virol Methods; 1989 Aug; 25(2):167-77. PubMed ID: 2476460 [TBL] [Abstract][Full Text] [Related]
24. Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe. Goudsmit J; Meloen RH; Brasseur R Intervirology; 1990; 31(6):327-38. PubMed ID: 1704000 [TBL] [Abstract][Full Text] [Related]
25. Epitopes of HIV-1 glycoproteins recognized by the human immune system. Laal S; Zolla-Pazner S Chem Immunol; 1993; 56():91-111. PubMed ID: 7680869 [No Abstract] [Full Text] [Related]
26. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries. Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247 [TBL] [Abstract][Full Text] [Related]
27. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection. Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821 [TBL] [Abstract][Full Text] [Related]
28. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1). Neurath AR; Strick N; Jiang S Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549 [TBL] [Abstract][Full Text] [Related]
29. Binding antibody to neutralizing epitope gp41 in HIV-1 subtype CRF 01_AE infection related to stage of disease. Srisurapanon S; Louisirirotchanakul S; Sumransurp K; Ratanasrithong M; Chuenchitra T; Jintakatkorn S; Wasi C Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):221-7. PubMed ID: 15906673 [TBL] [Abstract][Full Text] [Related]
30. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus. Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139 [TBL] [Abstract][Full Text] [Related]
31. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus. Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470 [TBL] [Abstract][Full Text] [Related]
32. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies. McCaffrey RA; Saunders C; Hensel M; Stamatatos L J Virol; 2004 Apr; 78(7):3279-95. PubMed ID: 15016849 [TBL] [Abstract][Full Text] [Related]
33. Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1. Klasse PJ; Blomberg J; Pipkorn R Viral Immunol; 1990; 3(2):89-98. PubMed ID: 1694431 [TBL] [Abstract][Full Text] [Related]
34. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. Purtscher M; Trkola A; Gruber G; Buchacher A; Predl R; Steindl F; Tauer C; Berger R; Barrett N; Jungbauer A AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1651-8. PubMed ID: 7888224 [TBL] [Abstract][Full Text] [Related]
35. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein. Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197 [TBL] [Abstract][Full Text] [Related]
36. Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody. Bugge TH; Lindhardt BO; Hansen LL; Kusk P; Hulgaard E; Holmbäck K; Klasse PJ; Zeuthen J; Ulrich K J Virol; 1990 Sep; 64(9):4123-9. PubMed ID: 1696634 [TBL] [Abstract][Full Text] [Related]
37. Murine monoclonal antibodies directed against the transmembrane protein gp41 of human immunodeficiency virus type 1 enhance its infectivity. Niedrig M; Bröker M; Walter G; Stüber W; Harthus HP; Mehdi S; Gelderblom HR; Pauli G J Gen Virol; 1992 Apr; 73 ( Pt 4)():951-4. PubMed ID: 1378882 [TBL] [Abstract][Full Text] [Related]
38. Effect of HIV-1 peptide presentation on the affinity constants of two monoclonal antibodies determined by BIAcore technology. Mani JC; Marchi V; Cucurou C Mol Immunol; 1994 Apr; 31(6):439-44. PubMed ID: 7514268 [TBL] [Abstract][Full Text] [Related]
39. Increased levels of antibodies against interferon-alpha in HIV-1 positive individuals may be explained by a common immunological epitope on the human interferon-alpha and HIV-1 gp41. Chen YH; Stoiber H; Dierich MP Immunol Lett; 1997 Jan; 55(1):15-8. PubMed ID: 9093876 [TBL] [Abstract][Full Text] [Related]
40. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41. Gorny MK; Zolla-Pazner S J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]